文献速递儿科与产科急症重症综合管理与镇静镇痛

全基因组测序重新分类婴儿死亡病因

Reclassification of the Etiology of Infant Mortality With Whole-Genome Sequencing.
PubMed 文献 · JAMA Netw Open · 2023-02-01
一句话结论婴儿死亡者中41%存在单基因遗传病,62%死亡证明未提及遗传病因,30%有可用治疗,部分死亡或可避免。

本研究为在加利福尼亚州圣迭戈县一家大型儿科医院系统开展的队列研究,纳入2015年1月至2020年12月接受诊断性全基因组测序(WGS)的546名0至1岁婴儿,其中112例死亡(20.5%)、434例急性病存活(79.5%)。在112例死亡婴儿中,单基因遗传病是最常见的可识别死因,46例(41%)共发现47种遗传病;其中39种(83%)此前已报告与儿童死亡率相关,14种(30%)有可改善结局的治疗。45例有死亡证明的婴儿中,28份(62%)未提及遗传病因;死后确诊的7例中5例若在症状出现或转入区域ICU时快速诊断性WGS,死亡可能避免。作者认为,提高新生儿遗传病诊断并立即实施治疗可能降低婴儿死亡率,需进一步研究以探索普遍性并衡量死亡率下降。

要点

  • 112例婴儿死亡中46例(41%)发现单基因遗传病,为最常见可识别死因,共47种遗传病。
  • 47种遗传病中39种(83%)此前已报告与儿童死亡率相关,14种(30%)有可改善结局的治疗。
  • 45例有死亡证明的婴儿中28份(62%)未提及遗传病因,提示常规死亡分类低估遗传病贡献。
  • 死后确诊遗传病的7例中5例,若在症状出现或转入区域ICU时快速诊断性WGS,死亡可能避免。
  • 作者认为提高新生儿遗传病诊断并立即治疗可能降低婴儿死亡率,需进一步研究普遍性并衡量死亡率下降。

适用人群与场景

  • 2015年1月至2020年12月在圣迭戈县一家大型儿科医院系统接受诊断性全基因组测序的0至1岁婴儿,共546名,其中112例死亡(20.5%)、434例急性病存活(79.5%)。
  • 死亡婴儿112例中54例为女孩(48.2%);8例(7.1%)非洲裔或黑人,1例(0.9%)美洲印第安人或阿拉斯加原住民,8例(7.1%)亚裔,48例(42.9%)西班牙裔,1例(0.9%)夏威夷原住民或太平洋岛民,34例(30.4%)白人。

处置流程与药物剂量

  • 婴儿接受全基因组测序可在生前或死后进行,并采用半自动化表型分析与诊断解读。

研究设计与关键结果

  • 队列研究,纳入546名0至1岁婴儿(112例死亡、434例急性病存活),在圣迭戈县一家大型儿科医院系统于2015年1月至2020年12月接受诊断性全基因组测序,数据分析于2015年至2022年进行。
  • 112例婴儿死亡中,单基因遗传病为最常见可识别死因,46例(41%)共发现47种遗传病;47种中39种(83%)此前已报告与儿童死亡率相关。
  • 45例有死亡证明的婴儿中28份(62%)未提及遗传病因;47种遗传病中14种(30%)有可改善结局的治疗。
  • 死后确诊遗传病的7例中5例,若在症状出现或转入区域ICU时进行快速诊断性全基因组测序,死亡可能避免。

证据类型、等级与局限

  • 证据类型:队列研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,提高新生儿遗传病诊断并立即实施治疗可能降低婴儿死亡率。
  • 作者指出,需进一步研究以探索这些发现的普遍性并衡量婴儿死亡率下降。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

IMPORTANCE: Understanding the causes of infant mortality shapes public health, surveillance, and research investments. However, the association of single-locus (mendelian) genetic diseases with infant mortality is poorly understood.

OBJECTIVE: To determine the association of genetic diseases with infant mortality.

DESIGN, SETTING, AND PARTICIPANTS: This cohort study was conducted at a large pediatric hospital system in San Diego County (California) and included 546 infants (112 infant deaths [20.5%] and 434 infants [79.5%] with acute illness who survived; age, 0 to 1 year) who underwent diagnostic whole-genome sequencing (WGS) between January 2015 and December 2020. Data analysis was conducted between 2015 and 2022.

EXPOSURE: Infants underwent WGS either premortem or postmortem with semiautomated phenotyping and diagnostic interpretation.

MAIN OUTCOMES AND MEASURES: Proportion of infant deaths associated with single-locus genetic diseases.

RESULTS: Among 112 infant deaths (54 girls [48.2%]; 8 [7.1%] African American or Black, 1 [0.9%] American Indian or Alaska Native, 8 [7.1%] Asian, 48 [42.9%] Hispanic, 1 [0.9%] Native Hawaiian or Pacific Islander, and 34 [30.4%] White infants) in San Diego County between 2015 and 2020, single-locus genetic diseases were the most common identifiable cause of infant mortality, with 47 genetic diseases identified in 46 infants (41%). Thirty-nine (83%) of these diseases had been previously reported to be associated with childhood mortality. Twenty-eight death certificates (62%) for 45 of the 46 infants did not mention a genetic etiology. Treatments that can improve outcomes were available for 14 (30%) of the genetic diseases. In 5 of 7 infants in whom genetic diseases were identified postmortem, death might have been avoided had rapid, diagnostic WGS been performed at time of symptom onset or regional intensive care unit admission.

CONCLUSIONS AND RELEVANCE: In this cohort study of 112 infant deaths, the association of genetic diseases with infant mortality was higher than previously recognized. Strategies to increase neonatal diagnosis of genetic diseases and immediately implement treatment may decrease infant mortality. Additional study is required to explore the generalizability of these findings and measure reduction in infant mortality.

来源:JAMA Netw Open,查看原文。版权归原作者所有。

参考来源

  1. Owen MJ, Wright MS, Batalov S, et al. Reclassification of the Etiology of Infant Mortality With Whole-Genome Sequencing. JAMA Netw Open. 2023. PMID: 36757698. doi:10.1001/jamanetworkopen.2022.54069

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。